TheraIndx is a cutting-edge Contract Research Organization (CRO) that specializes in providing comprehensive drug discovery and development services to pharmaceutical, biotechnology, and academic institutions worldwide. With a strong focus on innovation, scientific expertise, and advanced technologies.

They offers an extensive suite of preclinical drug development services, encompassing in vitro and in vivo studies. Their experienced team of scientists conducts pharmacology and toxicology studies to assess the safety, efficacy, and mechanism of action of potential drug candidates. Through state-of-the-art in vitro screening, target validation, and animal model testing, TheraIndx aids clients in making informed decisions regarding lead compound selection and optimization.